These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34824647)

  • 1. The Anti-Cancer Effect of A
    Fishman P; Jacobson KA; Ochaion A; Cohen S; Bar-Yehuda S
    Immunol Endocr Metab Agents Med Chem; 2007 Aug; 7():298-303. PubMed ID: 34824647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
    Fishman P; Bar-Yehuda S; Madi L; Rath-Wolfson L; Ochaion A; Cohen S; Baharav E
    Arthritis Res Ther; 2006; 8(1):R33. PubMed ID: 16507132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
    Madi L; Bar-Yehuda S; Barer F; Ardon E; Ochaion A; Fishman P
    J Biol Chem; 2003 Oct; 278(43):42121-30. PubMed ID: 12865431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
    Fishman P; Bar-Yehuda S; Ardon E; Rath-Wolfson L; Barrer F; Ochaion A; Madi L
    Anticancer Res; 2003; 23(3A):2077-83. PubMed ID: 12894581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A3 adenosine receptor agonist potentiates natural killer cell activity.
    Harish A; Hohana G; Fishman P; Arnon O; Bar-Yehuda S
    Int J Oncol; 2003 Oct; 23(4):1245-9. PubMed ID: 12964011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
    Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
    Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A3 adenosine receptor as a target for cancer therapy.
    Fishman P; Bar-Yehuda S; Madi L; Cohn I
    Anticancer Drugs; 2002 Jun; 13(5):437-43. PubMed ID: 12045454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
    Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P
    Clin Exp Rheumatol; 2006; 24(4):400-6. PubMed ID: 16956430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.
    Ren TH; Lv MM; An XM; Leung WK; Seto WK
    J Dig Dis; 2020 Jan; 21(1):38-45. PubMed ID: 31714673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
    Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
    Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
    Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
    Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
    Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
    Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.
    Kim TH; Kim YK; Woo JS
    Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of adenosine A3 receptor alleviates TNF-α-induced inflammation through inhibition of the NF-κB signaling pathway in human colonic epithelial cells.
    Ren T; Qiu Y; Wu W; Feng X; Ye S; Wang Z; Tian T; He Y; Yu C; Zhou Y
    Mediators Inflamm; 2014; 2014():818251. PubMed ID: 24864134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.
    Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y
    Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells.
    Lee JY; Jhun BS; Oh YT; Lee JH; Choe W; Baik HH; Ha J; Yoon KS; Kim SS; Kang I
    Neurosci Lett; 2006 Mar; 396(1):1-6. PubMed ID: 16324785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells.
    Nakashima KI; Iwao K; Inoue T; Haga A; Tsutsumi T; Mochita MI; Fujimoto T; Tanihara H
    Exp Eye Res; 2018 May; 170():160-168. PubMed ID: 29486164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
    Kim SJ; Min HY; Chung HJ; Park EJ; Hong JY; Kang YJ; Shin DH; Jeong LS; Lee SK
    Cancer Lett; 2008 Jun; 264(2):309-15. PubMed ID: 18321638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
    Rivo J; Zeira E; Galun E; Matot I
    Anesthesiology; 2004 Nov; 101(5):1153-9. PubMed ID: 15505451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.